Author: CBD-Intel
Lobbyists for ‘special interests’ accused of un-American activities on cannabis
Written by CBD-Intel || 23rd July 2021 || Business briefing |
Licensing issues look set to become the next big US lobbying battleground for cannabis as money moves on from the traditional legalisation-versus-prohibition field ...
Company behind the UK’s first medical cannabis vape aims to lead a revolution
Written by CBD-Intel || 22nd July 2021 || Business briefing |
London-listed Kanabo has launched the first medical cannabis vaping product in the UK in a move the company’s founder hopes will ultimately revolutionise the way medicines are administered ...
Malawi set for its first hemp harvest following legalisation and licensing
Written by CBD-Intel || 20th July 2021 || Business briefing |
Malawi is set to have its first hemp harvest this year following the licensing of 36 companies. However, despite hopes the plant could change the country’s economic fortunes, it will continue to be strictly regulated ...
Javid appointment as UK health minister raises slight hope for medical cannabis
Written by CBD-Intel || 19th July 2021 || Regulatory briefing |
Medical cannabis advocates are keen to see if Sajid Javid’s appointment as UK health secretary means he will continue his work from 2018, when he helped change the law on medicinal cannabis prescriptions ...CBD-Intel regulatory news in brief, 10th-16th July
Written by CBD-Intel || 16th July 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from the Germany, North Macedonia, Spain, Ukraine, Canada, US, Argentina, Brazil, Israel and Peru ...
From tax to social equity: three US states’ recreational cannabis rules compared
Written by CBD-Intel || 15th July 2021 || Regulatory briefing |
Three more states have been added to the growing list of US jurisdictions allowing adult use of recreational cannabis. And they have learned lessons on how to frame regulation from those that came before ...
A long process – Europe’s still asking questions about novel food submission
Written by CBD-Intel || 14th July 2021 || Business briefing |
A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA) ...
Euro cross-party group to push for EU harmony on medicinal cannabis rules
Written by CBD-Intel || 12th July 2021 || Regulatory briefing |
A new cross-party European parliamentary group wants to help patients across the European Union get better access to medical cannabis and advance the EU’s cannabis resolution of 2019 ...CBD-Intel regulatory news in brief, 3rd-9th July
Written by CBD-Intel || 9th July 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from the EU, Belgium, Portugal, Spain, US, Argentina and Brazil ...
CBD-Intel global alerts database July
Written by CBD-Intel || 9th July 2021 || Regulatory alerts roundup |
All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month.This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel...
Why the UK government might not follow task force advice on homegrown hemp
Written by CBD-Intel || 8th July 2021 || Blog |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
UN drugs division calls for a worldwide ban on all types of cannabis advertising
Written by CBD-Intel || 7th July 2021 || Regulatory briefing |
The United Nations (UN) drugs division is calling for a “comprehensive ban” on cannabis advertising to address the growing belief among young people that cannabis is not harmful ...CBD-Intel regulatory news in brief, 27th June-2nd July
Written by CBD-Intel || 2nd July 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Andorra, EU, Germany, Ireland, Italy, Spain, UK, Ukraine, Mexico, US and Uruguay ...
Mexican court rules recreational cannabis ban unconstitutional
Written by CBD-Intel || 2nd July 2021 || Regulatory briefing |
The ban on recreational cannabis consumption in Mexico was ruled unconstitutional by the Mexican Supreme Court on 28th June ...
More minor cannabinoids – could THCP and CBDP offer an interesting side dish?
Written by CBD-Intel || 1st July 2021 || Business briefing |
What are the potential implications for the cannabinoids market of two recently discovered compounds with chemical structures similar to those of CBD and THC – and what are they and their potential effects anyway? ...
Good news for Lithuanian hemp sector as use of the whole plant is approved
Written by CBD-Intel || 30th June 2021 || Regulatory briefing |
Lithuanian hemp cultivators and processors will now be able to use the whole hemp plant, including the flower, in their products after the country’s legislature, the Seimas, adopted amendments to the existing law ...
Freeing the ‘green pig’ – moves afoot to press France to legalise cannabis
Written by CBD-Intel || 29th June 2021 || Business briefing |
France is lagging behind its neighbours on medical cannabis – the potential “green pig” of French agriculture – according to an author of a report which called for it to be legalised on health and finance grounds ...
And now for our next Trip, let’s head for the US with $5m spending money
Written by CBD-Intel || 29th June 2021 || Business briefing |
CBD-infused drinks company Trip is making its way into the US after it raised $5m (£3.6m) in a Series A funding round last month ...
Regulatory report: CBD as a dietary supplement in the US and EU
Written by CBD-Intel || 28th June 2021 || Regulatory reports |
As CBD grows in popularity, its regulatory status remains poorly defined. In this report CBD-Intel reviews the regulatory framework of dietary supplements and where CBD fits, or would fit, within that framework ...
50 years on, Connecticut makes amends to those punished by the ‘war on drugs’
Written by CBD-Intel || 28th June 2021 || Regulatory briefing |
Lawmakers in the US state of Connecticut have legalised recreational cannabis in a measure that includes provisions aimed at social equity in a vote on the 50th anniversary of the so-called “war on drugs” ...CBD-Intel regulatory news in brief, 19th-26th June
Written by CBD-Intel || 25th June 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Denmark, France, Ireland, Italy, Portugal, Canada, Mexico, US, Chile and Colombia ...
Italian inter-ministerial decree ditched due to hemp association protests
Written by CBD-Intel || 25th June 2021 || Regulatory briefing |
A new inter-ministerial decree that aimed to prohibit the use of cannabis leaves and flowers in extraction was withdrawn after protests from hemp associations ...
Canada reveals plans to restrict flavours in inhalable cannabis products
Written by CBD-Intel || 25th June 2021 || Regulatory briefing |
The Canadian government has served notice of plans to restrict flavours in cannabis vaping products and inhaled cannabis extracts across the country, arguing that it will make those products less appealing to youth ...
UK debate reveals broad agreement on need to reform outdated drugs law
Written by CBD-Intel || 24th June 2021 || Regulatory briefing |
Members of Parliament from across the political spectrum in the UK believe the 1971 Misuse of Drugs Act is in urgent need of reform, after 50 years of “wasting lives” and holding back vital research ...
Brazil moves closer to legalising medical cannabis, despite president’s veto threat
Written by CBD-Intel || 21st June 2021 || Regulatory briefing |
A bill that would allow the cultivation and processing of hemp and cannabis in Brazil has passed an important committee vote in the country’s lower legislative chamber – but serious obstacles remain ...CBD-Intel regulatory news in brief, 12th-18th June
Written by CBD-Intel || 18th June 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Croatia, Germany, Italy, Lithuania, North Macedonia, UK, Ukraine, Canada and the...
Official report favours legalisation, but France is unlikely to budge on cannabis
Written by CBD-Intel || 17th June 2021 || Regulatory briefing |
Members of the French National Assembly appear unlikely to follow the recommendations made in a recent report on recreational cannabis, despite its scathing criticism of the current harsh regime ...
Nordic Oil seeks €5m and ‘emotional investment’ through crowd-funding
Written by CBD-Intel || 16th June 2021 || Business briefing |
Nordic Oil could become the largest European CBD brand to raise money through crowd-funding as it seeks to raise €3m-€5m through the Seedrs platform ...
Combining other topical ingredients with cannabinoids goes more than skin-deep
Written by CBD-Intel || 16th June 2021 || Business briefing |
Trends such as sustainability and organic plant-based ingredients are helping to drive the market for hemp and cannabinoid topical products even higher, with combination products all the rage ...
UK psychedelics fund puts £5m into seven companies to tackle mental health
Written by CBD-Intel || 14th June 2021 || Business briefing |
UK venture capital fund Neo Kuma has invested £5m across seven healthcare companies focused on the use of psychedelics to help combat mental health issues ...CBD-Intel regulatory news in brief, 5th-11th June
Written by CBD-Intel || 11th June 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Belgium, Bulgaria, Czech Republic, France, Lithuania, North Macedona, Portugal, Spain, UK, Ukraine, Canada, US, Brazil and Morocco ...
France to clarify regulation of CBD hemp extracts with upcoming decree
Written by CBD-Intel || 11th June 2021 || Regulatory briefing |
A draft ministerial decree to clarify the regulation of CBD in France is under consideration, but many in the industry are unhappy with the proposed measures ...
The battle for medical cannabis goes on in Mississippi after ballot is annulled
Written by CBD-Intel || 8th June 2021 || Regulatory briefing |
Mississippi supporters of medical cannabis are fighting to have their voices heard after a vote for legalisation was thrown out by the US state’s Supreme Court ...CBD-Intel regulatory news in brief, 29th May-4th June
Written by CBD-Intel || 4th June 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Ireland, Italy, Portugal, Spain, Ukraine, the US, Argentina and Colombia ...
New UK cannabis industry body brings together a wide range of expertise
Written by CBD-Intel || 3rd June 2021 || Blog |
A new UK cannabis industry association claims to be the first to bring together members from every aspect of the industry – with a range of more than 100 members already ...
It’s complicated: German court ruling adds further confusion to hemp law
Written by CBD-Intel || 3rd June 2021 || Regulatory briefing |
The legality of selling hemp flowers as well as hemp leaf tea in Germany is no clearer despite the recent ruling by the country’s highest court that low-THC industrial hemp flowers could – in principle – be sold...
Regulator’s labelling guidance could spell doom for UK sales of CBD-infused alcohol
Written by CBD-Intel || 1st June 2021 || Business briefing |
The UK alcohol industry's voluntary regulator denies being outright opposed to CBD alcoholic drinks – but moves made by one major brand suggests many see the writing on the wall for the niche sector ...CBD-Intel regulatory news in brief, 22nd-28th May
Written by CBD-Intel || 28th May 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Belgium, France, Denmark, Germany, Greece, Italy, Luxembourg, the US, China and Morocco ...
Initial results from Project Twenty21 reveal promise – and a few caveats
Written by CBD-Intel || 26th May 2021 || Business briefing |
CBD-Intel assesses how Project Twenty21 is faring as it seeks to construct a registry of medical cannabis users in the UK and Europe, providing real world data on potential efficacy ...
Another one bites the dust as Hawaii tries and fails again to legalise cannabis
Written by CBD-Intel || 25th May 2021 || Regulatory briefing |
Despite the island state's generally liberal outlook, and long association with cannabis culture, legalisation of recreational use remains a frustrated dream for many in Hawaii ...
Small steps towards regulation raise big hopes for cannabinoids in Argentina
Written by CBD-Intel || 24th May 2021 || Business briefing |
Early moves towards a regulatory framework that would allow a cannabinoid industry in Argentina have been welcomed by insiders who hope ultimately to match or surpass the progress made by other South American nations ...CBD-Intel regulatory news in brief, 15th-21st May
Written by CBD-Intel || 21st May 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from EU, France, Germany, Greece, Ireland, Lithuania, Switzerland, UK, US, Argentina, Australia, Brazil, Ecuador, Morocco and South Africa ...
EU Commission considers bringing CBD vapes under tobacco regulation
Written by CBD-Intel || 20th May 2021 || Regulatory briefing |
European tobacco control rules could be extended to specifically cover the vaping of CBD, a new report from the European Commission suggests ...
Is delta-8 THC a legal product in the US?
Written by CBD-Intel || 20th May 2021 || Blog |
CBD-Intel’s opinion from a reading of laws at the federal level is that – currently – delta-8 THC should be considered legal if derived from a legal hemp plant. This is because the federal definition of hemp encompasses...
What can we learn from the distribution of brands by main product category and retailer type in the UK?
Written by CBD-Intel || 14th May 2021 || Blog |
CBD-Intel’s new UK online report highlights a number of interesting market developments. Among them is the information that brand distribution provides. From a dominance perspective, more brands are now being listed for cosmetic than vape products. This shows...CBD-Intel regulatory news in brief, 8th-14th May
Written by CBD-Intel || 14th May 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Austria, Germany, Greece, Malta, Spain, the UK, the US, China, Japan, New Zealand, Panama and Uruguay ...
Global CBD stakeholders database
Written by CBD-Intel || 14th May 2021 || Regulatory trackers |
Use our newly updated directory of stakeholders in the global CBD sector to find the most relevant organisations in key markets, with full web, email, phone and address details. Available exclusively to CBD-Intel subscribers, this once-yearly updated database...
Cannabinoids, cannabis and pain: a promising area for further research
Written by CBD-Intel || 13th May 2021 || Business briefing |
Pain is a familiar part of everybody’s life, yet it remains a remarkably hard subject to study. It therefore is unsurprising that studies have come to differing conclusions on the use of cannabis and cannabinoids for pain relief...